FDA Inspection
Mikart LLCMikart LLC – FDA Inspection, Jan 18, 2019
Record Details
This FDA Inspection record concerns Mikart LLC, with an inspection on January 18, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
- People
- Rachael L. Derby (Issuing Officer)
- Steven J. Rush (Company Rep)
View Company Profile
ID · 99b98ff4-7b3b-49a6-8ee8-355340d5447b
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1076609
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 211.25(a)GMP Training Frequency
- 21 CFR 211.82(b)Quarantine Storage of Components
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Mikart LLC
14| Date | Classification | Office | Project area |
|---|---|---|---|
| August 10, 2026 | Not classified | Atlanta District Office | |
| April 26, 2022 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 8, 2021 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| May 30, 2019 | Not classified | Atlanta District Office | |
| August 23, 2018 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Mikart LLC
- FDA Inspection 1318096 - 2026-08-10
- FDA Inspection 1168215 - 2022-04-26
- FDA Inspection 1151501 - 2021-09-08
- FDA Inspection 1092848 - 2019-05-30
- FDA Inspection 1064850 - 2018-08-23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.